Search results for "Cardiovascular Disease"
Asthma flare-ups face new evidence, new therapies
This issue also covers changing use of aspirin for cardiovascular disease, decreases in the ability to smell, and dealing with the unexpected loss of a medical trainee.
https://immattersacp.org/archives/2019/03/asthma-flare-ups-face-new-evidence-new-therapies.htm
1 Mar 2019
ACC updates decision pathway on nonstatin drugs in ASCVD
Experts considered evidence from the FOURIER trial and the SPIRE-1 and SPIRE-2 trials, as well as evidence on addition of ezetimibe to statin therapy after acute coronary syndrome.
https://immattersacp.org/weekly/archives/2017/09/12/1.htm
12 Sep 2017
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
ADA issues updated position statement on hypertension and diabetes
The statement updates the ADA's 2003 position statement on this topic and summarizes clinical trials of intensive hypertension treatment strategies.
https://immattersacp.org/weekly/archives/2017/08/29/1.htm
29 Aug 2017
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
New options no panacea for depression
Internists can have the greatest impact by continuing to be the first point of contact, treating mild to moderate depression, and explaining what may be available if first-line options fall short.
https://immattersacp.org/archives/2019/09/new-options-no-panacea-for-depression.htm
1 Sep 2019
New dosing for ESAs and oseltamivir, warning on pioglitazone
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/09/fda.htm
1 Sep 2011
MKSAP Quiz: establish care for diabetes and hypertension
This week's quiz asks readers to evaluate a 60-year-old man with type 2 diabetes mellitus and hypertension who seeks to establish medical care.
https://immattersacp.org/weekly/archives/2011/10/04/3.htm
4 Oct 2011
Wearable tech shows promise in clinical care
Smart watches and fitness trackers could offer a remote connection to patients, as well as a way of tracking their progress on meeting health goals. But their application depends on the patient and the physician.
https://immattersacp.org/archives/2015/11/technology.htm
1 Nov 2015
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016